相似文献
1
Comparison of multiplex immunoassay platforms.
Clin Chem. 2010 Feb;56(2):314-8. doi: 10.1373/clinchem.2009.135087. Epub 2009 Dec 18.
2
How to: Measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays.
Psychoneuroendocrinology. 2017 Jan;75:72-82. doi: 10.1016/j.psyneuen.2016.10.010. Epub 2016 Oct 20.
3
Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology.
Malar J. 2011 May 9;10:115. doi: 10.1186/1475-2875-10-115.
4
Optimising the quantification of cytokines present at low concentrations in small human mucosal tissue samples using Luminex assays.
J Immunol Methods. 2013 Aug 30;394(1-2):1-9. doi: 10.1016/j.jim.2013.04.009. Epub 2013 May 1.
5
Fast and Efficient Measurement of Clinical and Biological Samples Using Immunoassay-Based Multiplexing Systems.
Methods Mol Biol. 2020;2102:129-147. doi: 10.1007/978-1-0716-0223-2_6.
6
Multiplex Immunoassay Profiling of Serum in Psychiatric Disorders.
Adv Exp Med Biol. 2017;974:149-156. doi: 10.1007/978-3-319-52479-5_10.
7
Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Cytokine X. 2020 Apr 28;2(2):100027. doi: 10.1016/j.cytox.2020.100027. eCollection 2020 Jun.
8
Performance of multiplex commercial kits to quantify cytokine and chemokine responses in culture supernatants from Plasmodium falciparum stimulations.
PLoS One. 2013;8(1):e52587. doi: 10.1371/journal.pone.0052587. Epub 2013 Jan 2.
9
Utility, reliability and reproducibility of immunoassay multiplex kits.
Methods. 2013 May 15;61(1):23-9. doi: 10.1016/j.ymeth.2013.01.003. Epub 2013 Jan 16.
10
Accuracy and reproducibility of a multiplex immunoassay platform: a validation study.
J Immunol Methods. 2011 Mar 31;367(1-2):33-9. doi: 10.1016/j.jim.2011.01.005. Epub 2011 Jan 26.
引用本文的文献
1
Multi-array Technology for Secreted Cytokine Profiling in a Nano-aerosol Exposed 3D Human Alveolar Cell Model.
Methods Mol Biol. 2025;2929:145-152. doi: 10.1007/978-1-0716-4595-6_11.
2
Lab-in-a-Tip: a multiplex immunoassay platform based on a self-assembled barcoded protein array.
Nat Commun. 2025 Apr 29;16(1):3990. doi: 10.1038/s41467-025-59390-1.
3
Sources of variability in Luminex bead-based cytokine assays: Evidence from twelve years of multi-site proficiency testing.
J Immunol Methods. 2024 Aug;531:113699. doi: 10.1016/j.jim.2024.113699. Epub 2024 May 31.
4
Quantification of Neuroinflammatory Markers in Blood, Cerebrospinal Fluid, and Resected Brain Samples Obtained from Patients.
Methods Mol Biol. 2024;2761:67-79. doi: 10.1007/978-1-0716-3662-6_6.
5
Major stress in early childhood strengthens the association between peripheral inflammatory activity and corticostriatal responsivity to reward.
Brain Behav Immun. 2024 Mar;117:215-223. doi: 10.1016/j.bbi.2024.01.013. Epub 2024 Jan 19.
6
Association of Blood Biomarkers of Inflammation With Acute Concussion in Collegiate Athletes and Military Service Academy Cadets.
Neurology. 2024 Jan 23;102(2):e207991. doi: 10.1212/WNL.0000000000207991. Epub 2023 Dec 15.
7
Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms.
Diagnostics (Basel). 2023 Sep 30;13(19):3101. doi: 10.3390/diagnostics13193101.
8
Variability of Replicates of Intraocular Inflammatory Biomarkers in Ocular Fluid Samples Analyzed with Multiplex Assays.
Clin Ophthalmol. 2023 Sep 8;17:2653-2663. doi: 10.2147/OPTH.S417821. eCollection 2023.
9
Comparison of test performance of two commonly used multiplex assays to measure micronutrient and inflammatory markers in serum: results from a survey among pregnant women in South Africa.
Br J Nutr. 2024 Jan 28;131(2):248-255. doi: 10.1017/S0007114523001782. Epub 2023 Aug 10.
10
Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients.
Int J Mol Sci. 2023 Jul 18;24(14):11579. doi: 10.3390/ijms241411579.
本文引用的文献
1
Identification of diagnostic biomarkers for infection in premature neonates.
Mol Cell Proteomics. 2008 Oct;7(10):1863-75. doi: 10.1074/mcp.M800175-MCP200. Epub 2008 Jul 13.
2
Cytokine quantitation: technologies and applications.
Front Biosci. 2007 May 1;12:4682-95. doi: 10.2741/2418.
3
Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies.
Expert Rev Mol Diagn. 2007 Jan;7(1):87-98. doi: 10.1586/14737159.7.1.87.
4
Biomarker discovery and validation.
Clin Chem. 2006 Sep;52(9):1635-7. doi: 10.1373/clinchem.2006.074492.
5
Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
Nat Biotechnol. 2006 Aug;24(8):971-83. doi: 10.1038/nbt1235.
6
Proteomics and heart disease: identifying biomarkers of clinical utility.
Expert Rev Proteomics. 2006 Apr;3(2):237-49. doi: 10.1586/14789450.3.2.237.
7
Multiplexed protein measurement: technologies and applications of protein and antibody arrays.
Nat Rev Drug Discov. 2006 Apr;5(4):310-20. doi: 10.1038/nrd2006.
8
Multiplexed cytokine sandwich immunoassays: clinical applications.
Methods Mol Med. 2005;114:223-32. doi: 10.1385/1-59259-923-0:223.
9
Proteomics: beginning to realize its promise?
Arthritis Rheum. 2004 Dec;50(12):3741-4. doi: 10.1002/art.20796.
10
Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.
Lupus. 2004;13(5):304-11. doi: 10.1191/0961203303lu1017oa.
Zotero 插件